Recalls / Active ingredient / Buprenorphine
Buprenorphine
1 FDA drug recall involving the active ingredient “Buprenorphine”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2020-09-04 | Class II | Buprenorphine Transdermal System 5 mcg/hour, 4 transdermal systems/4 disposal units per carton, Rx Only, Manuf | Teva Pharmaceuticals USA |